Neurology
Fred Lublin, M.D.
Saunders Family Professor of Neurology; Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Dr. Lublin has a special interest in immune functions and abnormalities affecting the nervous system. He has been involved in both basic science and clinical research. He and his colleagues were among the first in the country involved with studies of Interferon beta-1b, which was approved by the Food & Drug Administration in 1993 to treat the relapsing-remitting form of Multiple Sclerosis. He has since been involved in the development of nearly all of the currently available agents to treat MS.
50+
Years in Practice
Credentials
Board Certifications
- Neurology (American Board of Psychiatry and Neurology)
Education & Training
- Thomas Jefferson University — MD, 1972
- Albert Einstein College of Medicine/Bronx Municipal Hospital Center — Internship, Internal Medicine
- New York Hospital/Weill Cornell Medical Center — Residency, Neurology
Peer Recognition
- Castle Connolly — Top Doctor
2002-2026 (25 years)
Recognition & Leadership
Awards & Honors
- 2025 June Halper Visionary Award
- 2019 Award for Recognition of Leadership and Dedication in Applying Medical Education to Improve Care of Patients with Multiple Sclerosis
- 2019 June Halpern Lifetime Achievement Award
- 2019 Presidential Lecture
- 2017 Clifford Goldsmith Award
Leadership Roles
- Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai
- Saunders Family Professor of Neurology, Icahn School of Medicine at Mount Sinai
- Chairman, Research Programs Advisory Committee, National Multiple Sclerosis Society (2000-present)
- Chairman, National MS Society Advisory Committee on Clinical Trials
- Co-Chair, NINDS MS Common Data Element Committee
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Mount Sinai Hospital
Languages
English
Experience
50+ years in practice